Maria Cristina Mingari Selected Research

Maria Cristina Mingari Research Topics

Disease

54	Neoplasms (Cancer) 01/2023 - 01/2002
18	Leukemia 01/2022 - 03/2005
14	Melanoma (Melanoma, Malignant) 01/2023 - 03/2009
5	Infections 01/2023 - 02/2007
4	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 12/2002
3	Inflammation (Inflammations) 07/2022 - 08/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2017
2	Dry Eye Syndromes (Dry Eye Syndrome) 07/2022 - 10/2010
2	Ovarian Neoplasms (Ovarian Cancer) 02/2020 - 08/2011
2	Carcinoma (Carcinomatosis) 08/2019 - 05/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 11/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2014 - 05/2014
2	Seroma 04/2014 - 06/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2009 - 12/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Ascites 02/2020
1	Ovarian Epithelial Carcinoma 02/2020
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

14	LigandsIBA 01/2020 - 07/2003
12	CytokinesIBA 01/2021 - 02/2008
5	Interleukin-15 (Interleukin 15)IBA 01/2023 - 09/2016
4	HLA-DR Antigens (HLA-DR)IBA 07/2022 - 02/2008
4	Proteins (Proteins, Gene)FDA Link 02/2020 - 06/2010
4	Interleukin-2 (IL2)IBA 08/2019 - 02/2013
4	Histocompatibility Antigens Class IIBA 10/2016 - 01/2002
3	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2020
3	AntigensIBA 01/2021 - 07/2003
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2009
3	Syndecan-1 (Syndecan 1)IBA 08/2019 - 05/2013
3	Protein Isoforms (Isoforms)IBA 08/2019 - 03/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2014
3	Monoclonal AntibodiesIBA 01/2019 - 05/2013
3	PerforinIBA 12/2015 - 01/2012
3	KIR ReceptorsIBA 01/2014 - 08/2002
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2021 - 04/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2019
2	NivolumabIBA 01/2020 - 01/2019
2	Fibronectins (Fibronectin)IBA 08/2019 - 11/2015
2	L19-IL2 immunocytokineIBA 08/2019 - 11/2015
2	EpitopesIBA 12/2017 - 03/2009
2	HMGB1 Protein (HMG1)IBA 01/2016 - 12/2015
2	Natural Killer Cell ReceptorsIBA 12/2015 - 02/2007
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015 - 05/2013
2	NectinsIBA 03/2005 - 02/2005
1	NAD (NADH)IBA 01/2023
1	VemurafenibIBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Broncho-VaxomIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	SuspensionsIBA 07/2022
1	Loteprednol Etabonate (Alrex)FDA Link 07/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2022
1	Histones (Histone)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2020
1	Carrier Proteins (Binding Protein)IBA 02/2020
1	Tyrosine (L-Tyrosine)FDA Link 02/2020
1	Interleukin-27 (Interleukin 27)IBA 02/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	matrigelIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	pembrolizumabIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2016
1	mirdametinibIBA 09/2016
1	Interleukin-18 (Interleukin 18)IBA 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016
1	Chemotactic FactorsIBA 12/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 09/2015
1	Adenosine (Adenocard)FDA LinkGeneric 09/2015
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2014
1	Proto-Oncogene Proteins c-metIBA 06/2014
1	HLA-G Antigens (HLA G)IBA 05/2014

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2011
17	Immunotherapy 01/2023 - 12/2009
10	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2009
5	Transplantation 01/2019 - 03/2009
2	Stem Cell Transplantation 01/2017 - 11/2009
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2006 - 12/2002
1	Investigational Therapies (Experimental Therapy) 03/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Immunomodulation 12/2015